Monogram Orthopaedics, Inc. (MGRM)
USD 2.31
(-14.78%)
USD 2.31
(-14.78%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 3.18 Million USD | -66.65% |
| 2022 | 9.54 Million USD | 83.05% |
| 2021 | 5.21 Million USD | 66.71% |
| 2020 | 3.12 Million USD | 8.0% |
| 2019 | 2.89 Million USD | 12.41% |
| 2018 | 2.57 Million USD | 144.83% |
| 2017 | 1.05 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 2.31 Million USD | -27.27% |
| 2024 Q2 | 2.77 Million USD | 19.9% |
| 2023 FY | 3.18 Million USD | -66.65% |
| 2023 Q4 | 3.18 Million USD | -49.99% |
| 2023 Q1 | 9.78 Million USD | 2.54% |
| 2023 Q3 | 6.36 Million USD | -25.26% |
| 2023 Q2 | 8.51 Million USD | -12.98% |
| 2022 Q4 | 9.54 Million USD | 0.0% |
| 2022 Q2 | 5.91 Million USD | 0.0% |
| 2022 Q1 | - USD | -100.0% |
| 2022 FY | 9.54 Million USD | 83.05% |
| 2021 Q1 | 3.47 Million USD | 11.31% |
| 2021 FY | 5.21 Million USD | 66.71% |
| 2021 Q4 | 5.21 Million USD | 0.0% |
| 2021 Q3 | 5.21 Million USD | 49.78% |
| 2021 Q2 | 3.47 Million USD | 0.0% |
| 2020 FY | 3.12 Million USD | 8.0% |
| 2020 Q4 | 3.12 Million USD | 0.0% |
| 2020 Q3 | 3.12 Million USD | 57.74% |
| 2020 Q2 | 1.98 Million USD | 0.0% |
| 2020 Q1 | 1.98 Million USD | -31.53% |
| 2019 Q4 | 2.89 Million USD | 0.0% |
| 2019 Q3 | 2.89 Million USD | 17.99% |
| 2019 Q2 | 2.45 Million USD | 0.0% |
| 2019 Q1 | 2.45 Million USD | -4.73% |
| 2019 FY | 2.89 Million USD | 12.41% |
| 2018 Q4 | 2.57 Million USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2018 Q3 | 2.57 Million USD | 0.0% |
| 2018 FY | 2.57 Million USD | 144.83% |
| 2017 FY | 1.05 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 93.792% |
| BrainsWay Ltd. | 15.31 Million USD | 79.222% |
| Cerus Corporation | 144.3 Million USD | 97.795% |
| Envoy Medical, Inc. | 9.4 Million USD | 66.157% |
| electroCore, Inc. | 8.94 Million USD | 64.428% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | 40.435% |
| IceCure Medical Ltd | 4.24 Million USD | 25.078% |
| Inogen, Inc. | 121.38 Million USD | 97.379% |
| OrthoPediatrics Corp. | 72.56 Million USD | 95.615% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 89.243% |
| MaxCyte, Inc. | 36.1 Million USD | 91.187% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -72.191% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -648.198% |
| Orthofix Medical Inc. | 326.58 Million USD | 99.026% |
| PAVmed Inc | 57.13 Million USD | 94.431% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 87.504% |
| RxSight, Inc. | 22.18 Million USD | 85.659% |
| Sight Sciences, Inc. | 46.43 Million USD | 93.148% |
| SI-BONE, Inc. | 61.05 Million USD | 94.788% |
| TELA Bio, Inc. | 59.16 Million USD | 94.622% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 97.208% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 69.164% |
| Acutus Medical, Inc. | 54.83 Million USD | 94.198% |
| Talis Biomedical Corporation | 29.22 Million USD | 89.112% |
| Spectral AI, Inc. | 12.4 Million USD | 74.341% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 86.246% |
| CVRx, Inc. | 39.28 Million USD | 91.9% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 73.391% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -30.982% |
| Bioventus Inc. | 589.79 Million USD | 99.46% |
| Venus Concept Inc. | 107.1 Million USD | 97.029% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 93.841% |
| LivaNova PLC | 1.15 Billion USD | 99.724% |
| 908 Devices Inc. | 37.49 Million USD | 91.513% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.548% |
| Nemaura Medical Inc. | 26.37 Million USD | 87.937% |
| NeuroPace, Inc. | 86.99 Million USD | 96.342% |
| LENSAR, Inc. | 22.4 Million USD | 85.801% |
| Apyx Medical Corporation | 52.31 Million USD | 93.918% |
| Cutera, Inc. | 518.12 Million USD | 99.386% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 89.15% |
| BioSig Technologies, Inc. | 4.68 Million USD | 32.082% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 94.548% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 85.192% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.855% |
| Axonics, Inc. | 82.35 Million USD | 96.136% |
| Outset Medical, Inc. | 190.91 Million USD | 98.333% |
| IRIDEX Corporation | 24.91 Million USD | 87.228% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 97.433% |
| IRadimed Corporation | 20.73 Million USD | 84.655% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -90.08% |
| INVO Bioscience, Inc. | 19.99 Million USD | 84.086% |
| Telesis Bio, Inc. | 40.87 Million USD | 92.215% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 92.199% |
| Varex Imaging Corporation | 668.6 Million USD | 99.524% |
| Quipt Home Medical Corp. | 136.29 Million USD | 97.665% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 10.92% |
| Pulmonx Corporation | 60.63 Million USD | 94.752% |
| Dynatronics Corporation | 11.78 Million USD | 72.989% |
| Modular Medical, Inc. | 2.27 Million USD | -40.05% |
| ReShape Lifesciences Inc. | 4.06 Million USD | 21.704% |
| Semler Scientific, Inc. | 6.27 Million USD | 49.251% |
| InMode Ltd. | 75.91 Million USD | 95.808% |
| Bruker Corporation | 2.83 Billion USD | 99.888% |
| Cytosorbents Corporation | 29.98 Million USD | 89.388% |
| DexCom, Inc. | 4.19 Billion USD | 99.924% |
| Align Technology, Inc. | 2.45 Billion USD | 99.87% |
| Viveve Medical, Inc. | 10.84 Million USD | 70.665% |
| ZimVie Inc. | 795.85 Million USD | 99.6% |
| Movano Inc. | 5.97 Million USD | 46.719% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 96.958% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -648.198% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 73.391% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.502% |
| Profound Medical Corp. | 12.66 Million USD | 74.878% |
| Insulet Corporation | 1.85 Billion USD | 99.829% |
| enVVeno Medical Corporation | 2.43 Million USD | -30.675% |
| Surmodics, Inc. | 65.82 Million USD | 95.166% |
| iCAD, Inc. | 8 Million USD | 60.231% |
| Nuwellis, Inc. | 6.78 Million USD | 53.069% |
| Biotricity, Inc. | 35.91 Million USD | 91.141% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 98.573% |
| Aethlon Medical, Inc. | 2.47 Million USD | -28.322% |
| InspireMD, Inc. | 8.14 Million USD | 60.919% |
| PAVmed Inc. | 57.13 Million USD | 94.431% |
| BIOLASE, Inc. | 35.34 Million USD | 90.998% |
| Beyond Air, Inc. | 29.77 Million USD | 89.313% |
| FONAR Corporation | 57.45 Million USD | 94.462% |
| AxoGen, Inc. | 101.16 Million USD | 96.855% |
| Vivani Medical, Inc. | 25.03 Million USD | 87.291% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 96.376% |
| Inari Medical, Inc. | 209.32 Million USD | 98.48% |
| UFP Technologies, Inc. | 118.04 Million USD | 97.304% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 74.927% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -45.573% |
| Tenon Medical, Inc. | 5.56 Million USD | 42.843% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -78.861% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 81.956% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.899% |
| Sintx Technologies, Inc. | 6.59 Million USD | 51.738% |
| NanoVibronix, Inc. | 2.68 Million USD | -18.464% |
| Quanterix Corporation | 78.08 Million USD | 95.925% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | 10.92% |
| Sensus Healthcare, Inc. | 4.88 Million USD | 34.863% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.695% |
| TransMedics Group, Inc. | 568.84 Million USD | 99.441% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 80.926% |
| NeuroMetrix, Inc. | 1.33 Million USD | -138.683% |
| Hyperfine, Inc. | 9.8 Million USD | 67.531% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 98.728% |
| Biomerica, Inc. | 2.66 Million USD | -19.487% |
| Bone Biologics Corporation | 831.4 Thousand USD | -282.72% |
| AVITA Medical, Inc. | 19.86 Million USD | 83.982% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -61.219% |
| Silk Road Medical, Inc | 114.15 Million USD | 97.213% |